Veraxa Biotech (VRXA) Stock Price, News & Analysis
Company Description
Veraxa Biotech (NASDAQ: VRXA) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $284.2M, ranking #4,393 among all listed U.S. companies by market cap.
This page collects what Stock Titan holds for VRXA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Veraxa Biotech (VRXA) stock last closed at $1.98. At a market capitalization of $284.2M, VRXA is classified as a micro-cap stock with approximately 141.4M shares outstanding.
VRXA Rankings
Latest News
Veraxa Biotech has 10 recent news articles, with the latest published yesterday. Of the recent coverage, 2 articles coincided with positive price movement and 6 with negative movement. Key topics include partnership, AI, clinical trial. View all VRXA news →
SEC Filings
Veraxa Biotech has filed 5 recent SEC filings, including 3 Form 6-K, 1 Form 20-F, 1 Form SCHEDULE 13D. The most recent filing was submitted on July 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VRXA SEC filings →
Financial Highlights
Upcoming Events
VXA-102 IND/CTA readiness
Capital band expiry
Veraxa Biotech has 2 upcoming scheduled events. The next event, "VXA-102 IND/CTA readiness", is scheduled for January 1, 2028 (in 521 days). Investors can track these dates to stay informed about potential catalysts that may affect the VRXA stock price.
Short Interest History
Short interest in Veraxa Biotech (VRXA) currently stands at 240.6 thousand shares, up 82.4% from the previous reporting period, representing 0.1% of the float. Since June 2026, short interest has increased by 2263.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Veraxa Biotech (VRXA) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
VRXA Company Profile & Sector Positioning
Veraxa Biotech (VRXA) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #129 among all tracked companies.